Mitsuo Shimada

971 total citations
19 papers, 805 citations indexed

About

Mitsuo Shimada is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Mitsuo Shimada has authored 19 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Mitsuo Shimada's work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Mitsuo Shimada is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Mitsuo Shimada collaborates with scholars based in Japan and United States. Mitsuo Shimada's co-authors include Keizō Sugimachi, Zhi Rong Qian, Eiji Kudo, Masahiko Nakasono, Yoshiyuki Bando, Toshihito Tanahashi, Katsuhiko Yoshimoto, Toshiaki Sano, Hideaki Uchiyama and Tomoharu Yoshizumi and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Annals of Surgery.

In The Last Decade

Mitsuo Shimada

17 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuo Shimada Japan 12 340 331 209 185 183 19 805
Weiqiang Ju China 17 400 1.2× 411 1.2× 261 1.2× 249 1.3× 113 0.6× 74 948
Anand Ghanekar Canada 14 188 0.6× 243 0.7× 141 0.7× 235 1.3× 71 0.4× 28 845
Belinda Sánchez Pérez Spain 15 248 0.7× 310 0.9× 150 0.7× 144 0.8× 249 1.4× 89 809
Hiroteru Kamimura Japan 16 251 0.7× 142 0.4× 245 1.2× 141 0.8× 171 0.9× 86 867
Te‐Sheng Chang Taiwan 14 278 0.8× 100 0.3× 305 1.5× 154 0.8× 109 0.6× 50 678
Fausto Zamboni Italy 21 785 2.3× 371 1.1× 705 3.4× 262 1.4× 61 0.3× 44 1.2k
Shigeki Yokomuro Japan 16 426 1.3× 701 2.1× 262 1.3× 272 1.5× 241 1.3× 49 1.1k
Eytan Mor Israel 22 896 2.6× 1.1k 3.4× 472 2.3× 322 1.7× 97 0.5× 47 1.7k
Yonson Ku Japan 15 127 0.4× 264 0.8× 114 0.5× 90 0.5× 179 1.0× 52 544
Stefan Munker Germany 15 194 0.6× 138 0.4× 138 0.7× 166 0.9× 217 1.2× 37 634

Countries citing papers authored by Mitsuo Shimada

Since Specialization
Citations

This map shows the geographic impact of Mitsuo Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Shimada more than expected).

Fields of papers citing papers by Mitsuo Shimada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuo Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Shimada. The network helps show where Mitsuo Shimada may publish in the future.

Co-authorship network of co-authors of Mitsuo Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuo Shimada. A scholar is included among the top collaborators of Mitsuo Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuo Shimada. Mitsuo Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kawaguchi, Yoshikuni, Kiyoshi Hasegawa, Kosuke Kashiwabara, et al.. (2025). Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial). Journal of Clinical Oncology. 43(23). 2628–2638. 2 indexed citations
2.
3.
Tokunaga, Takuya, Masato Yoshikawa, & Mitsuo Shimada. (2024). The introduction of surgical telementoring systems in rural hospitals. World Journal of Surgery. 49(1). 84–88.
4.
Ikemoto, Tetsuya, Rui Feng, Shinichiro Yamada, et al.. (2019). In vitro and in vivo effects of insulin-producing cells generated by xeno-antigen free 3D culture with RCP piece. Scientific Reports. 9(1). 10759–10759. 21 indexed citations
5.
Ikemoto, Tetsuya, Mitsuo Shimada, Yuji Morine, & Satoru Imura. (2014). A Case of a Solid Pseudopapillary Neoplasm of the Pancreas with Recurrence as Peritoneal Dissemination 16 Years after the Initial Operation. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75(10). 2871–2876. 2 indexed citations
6.
Shimada, Mitsuo, Hideaki Uchiyama, Toru Ikegami, et al.. (2012). The beneficial effects of Kampo medicine Dai-ken-chu-to after hepatic resection: a prospective randomized control study.. PubMed. 59(119). 2290–4. 16 indexed citations
7.
Qian, Zhi Rong, Masahiko Nakasono, Toshihito Tanahashi, et al.. (2010). High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. British Journal of Cancer. 102(5). 908–915. 210 indexed citations
8.
Tanaka, Shinji, K Sugimachi, Toshifumi Kameyama, et al.. (2003). Human Wisp1v, A Member of the Ccn Family, Is Associated With Invasive Cholangiocarcinoma. Hepatology. 37(5). 1122–1129. 67 indexed citations
9.
Hinoshita, Eiji, Kenichi Taguchi, Takeshi Uchiumi, et al.. (2001). Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. Journal of Hepatology. 35(6). 765–773. 62 indexed citations
10.
Noguchi, K, Munechika Enjoji, Hidehiro Nishi, et al.. (2001). Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Letters. 168(2). 197–202. 45 indexed citations
11.
Nishizaki, Takashi, Shoji Hiroshige, Koji Hashimoto, et al.. (2001). Small Graft for Living Donor Liver Transplantation. Annals of Surgery. 233(4). 575–580. 159 indexed citations
12.
Shimada, Mitsuo, Tatsuya Rikimaru, K Sugimachi, et al.. (2000). The Importance of Hepatic Resection for Hepatocellular Carcinoma Originating From Nonfibrotic Liver. Journal of the American College of Surgeons. 191(5). 531–537. 44 indexed citations
13.
Nishizaki, T, K. Kishikawa, Tomoharu Yoshizumi, et al.. (2000). DOMINO LIVER TRANSPLANTATION FROM A LIVING RELATED DONOR. Transplantation. 70(8). 1236–1239. 11 indexed citations
14.
Hashizume, Makoto, Mitsuo Shimada, & Keizo Sugimachi. (2000). Laparoscopic hepatectomy: new approach for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery. 7(3). 270–275. 32 indexed citations
15.
Shimada, Mitsuo, Hirofumi Hasegawa, Tomonobu Gion, et al.. (1998). Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 27(6). 1567–1571. 81 indexed citations
16.
Shimada, Mitsuo, Kiyoshi Kajiyama, Hirofumi Hasegawa, et al.. (1998). Role of Adhesion Molecule Expression and Soluble Fractions in Hepatic Resection 1 1This work was supported in part by a Grant-in-Aid (Grant 08770975) from the Ministry of Education, Science and Culture in Japan.. Journal of the American College of Surgeons. 186(5). 534–541. 9 indexed citations
17.
Matsumata, Takashi, Akinobu Taketomi, Yasuhiro Fujiwara, et al.. (1997). Renal function after elective hepatic resection.. PubMed. 43(9). 602–7. 8 indexed citations
18.
Matsumata, Takashi, Katsuhiko Yanaga, Mitsuo Shimada, et al.. (1995). Occurrence of intraperitoneal septic complications after hepatic resections between 1985 and 1990. Surgery Today. 25(1). 49–54. 11 indexed citations
19.
Shimada, Mitsuo, et al.. (1994). Modulation of coagulation and fibrinolysis in hepatic resection: A randomized prospective control study using antithrombin III concentrates. Thrombosis Research. 74(2). 105–114. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiqiang Ju Breakdown of academic impact, for papers by Anand Ghanekar Breakdown of academic impact, for papers by Belinda Sánchez Pérez Breakdown of academic impact, for papers by Hiroteru Kamimura Breakdown of academic impact, for papers by Te‐Sheng Chang Breakdown of academic impact, for papers by Fausto Zamboni Breakdown of academic impact, for papers by Shigeki Yokomuro Breakdown of academic impact, for papers by Eytan Mor Breakdown of academic impact, for papers by Yonson Ku Breakdown of academic impact, for papers by Stefan Munker
Rankless by CCL
2026